Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Hair pattern in androgenetic alopecia overlaps with scalp and bone demarcations, with distinct gene profiles affecting susceptibility.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Wharton’s Jelly stem cells from the umbilical cord improve skin healing and hair growth without scarring.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Fissistigma oldhamii has compounds that help with pain, inflammation, and other health issues.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Afatinib often causes skin problems that need proactive management.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Metformin may help treat neuroendocrine tumors.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Nivolumab can cause hair loss as a rare side effect.

New cancer treatments aim to reduce side effects and improve effectiveness.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.